References
- Borkenstein M, Muntean W. Effects of growth hormone on the Factor VIII complex in patients with growth hormone deficiency. Metabolism 1984; 33: 1065–7
- Ingerslev J, Christensen P D, Stenbjerg S, Møller N, Ørskov H, Christiansen J S. Diabetes-like alterations in haemostatic parameters after one week's growth hormone administration in normal man. J Diabetic Complications 1989; 3: 103–6
- Sarji K E, Levine J H, Nair R MG, Sagel J, Colwell J A. Relation between growth hormone levels and von Willebrand factor activity. J Clin Endocrinol Metab 1977; 45: 853–6
- Porta M, Maneschi F, White M C, Kohner E M. Twenty-five hour variations of von Willebrand factor and Factor VHI-related antigen in diabetic retinopathy. Metabolism 1981; 695–9
- Lowe G DO, Middleton S M, Hay I D. Effects of growth hormone, glucose and insulin on the Factor VIII complex. Thrombosis Research 1982; 28: 201–11
- Lundbak K, Christensen N J, Jensen V A, et al. Diabetes, diabetic angiopathy, and growth hormone. The Lancet 1970; ii: 131–3
- Christiansen N J, Terkildsen A B. Quantitative measurements of skin capillary resistance in hypo-physectomized long-term diabetics. Diabetes 1971; 20: 297–301
- Fuller J H, Keen H, Jarret R J, et al. Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 2: 964–6
- Jørgensen J OL, Pedersen S A, Thuesen L, et al. Beneficial effects of growth hormone therapy in GH deficient adults. The Lancet 1989; i: 1221–5
- Ingerslev J, Stenbjerg S. Enzyme-linked immunosorbent assay (ELISA) for Factor VIII coagulant antigen (CAg) using haemophilic antibodies. Brit J Haematol 1986; 62: 325–32
- Ingerslev J. A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 1987; 47: 143–9
- Laurell C B. Quantitative estimation of proteins by electrophoresis in agarose gels containing antibodies. Analytical Chemistry 1966; 15: 45–52
- Ørskov H, Thomsen H G, Yde H. Wick chromatography for rapid and reliable immunoassay of insulin, glucagon and growth hormone. Nature 1968; 219: 193–5
- Jørgensen J OL, Flyvbjerg A, Lauritzen T, Alberti K GMM, Ørskov H, Christiansen J S. Dose-response studies with biosynthetic human growth hormone (GH) in GH deficient patients. J Clin Endocrinol Metab 1988; 67: 36–40
- Pocock S J. A practical approach. Wiley, Chichester 1987; 112–22
- Kornerup T. Capillary fragility and diabetic retinopathy. Acta Ophthal 1955; 33: 583–98
- Hart A, Cohen H. Capillary fragility studies in diabetes. Brit Med J 1969; 2: 89–91
- Hansen A AP, Johansen K. Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and GH in normal and juvenile diabetes. Diabetologia 1970; 6: 27–33